Conavi Medical Cash Flow Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023
Net Income	-16.19	-20.52	-43.62	7.22	7.22
Depreciation & Amortization	0.72	0.51	0.53	0.28	0.28
Stock-Based Compensation	0.61	0.44	0.26	1.45	1.45
Other Adjustments	-4.38	-2.64	17.9	1.92	1.92
Change in Receivables	0.34	0.69	0.06	1.52	1.52
Changes in Inventories	0.03	1.27	1.39	-	-
Changes in Accounts Payable	-0.02	-4.84	2.45	-6.99	-6.99
Changes in Income Taxes Payable	0.01	0	0.02	-	-
Changes in Unearned Revenue	-0.03	0.47	-0.22	-1.71	-1.71
Changes in Other Operating Activities	-2.26	-0.79	0.63	-	-
Operating Cash Flow	-20.62	-25.1	-20.15	2.38	2.38
Capital Expenditures	-0.07	-0.07	-0.58	-	-
Purchases of Intangible Assets	-0.21	-0.11	-0.27	-0.37	-0.37
Other Investing Activities	-	3.75	-	-	-
Investing Cash Flow	-0.29	3.57	-0.85	-0.26	-0.26
Long-Term Debt Issued	-	-	8.19	-	-
Long-Term Debt Repaid	-0.59	-0.55	-0.62	-	-
Net Long-Term Debt Issued (Repaid)	-0.59	-0.55	7.58	-	-
Issuance of Common Stock	-0.06	28.47	0.01	-	-
Net Common Stock Issued (Repurchased)	-0.06	28.47	0.01	-	-
Other Financing Activities	-1	-0.98	-0.32	-0.07	-0.07
Financing Cash Flow	16.79	26.94	7.26	-0.79	-0.79
Net Cash Flow	-4.12	5.41	-13.73	1.33	1.33
Free Cash Flow	-20.7	-25.17	-20.72	2.38	2.38
FCF Margin	-2931.44%	-275.96%	-958.95%	9.65%	9.65%
Free Cash Flow Per Share	-0.21	-0.44	-3.36	0.48	0.48
Levered Free Cash Flow	-22.74	-13	-5.13	-0.72	-0.72
Unlevered Free Cash Flow	-16.67	-23.29	-22.01	-0.21	-0.21

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.